Semler Scientific Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Semler Scientific has been growing earnings at an average annual rate of 7.7%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 16.9% per year. Semler Scientific's return on equity is 20.2%, and it has net margins of 25.6%.
Wichtige Informationen
7.7%
Wachstumsrate der Gewinne
6.6%
EPS-Wachstumsrate
Medical Equipment Wachstum der Industrie | 8.9% |
Wachstumsrate der Einnahmen | 16.9% |
Eigenkapitalrendite | 20.2% |
Netto-Marge | 25.6% |
Nächste Ertragsaktualisierung | 04 Nov 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%
Nov 02Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders
Aug 14The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet
Jul 18We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease
May 08Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)
Apr 17Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?
Jan 11Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 07What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?
Apr 07Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 14Semler Scientific: Growth, Profits, And Valuation Models Support A Buy
Aug 02Semler Scientific: A Small Company Solving A Big Problem
Apr 21Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade
Mar 08Semler Scientific: Why I'm Buying
Mar 05Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?
Mar 02Semler's Unique Business Model Is Fueling Profitable Growth
Feb 23Better Price For Semler Is Likely
Jan 05Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem
Nov 12It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers
Oct 15Semler Scientific: Rapidly Growing Medical Device Company
Oct 14There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump
Oct 14Aufschlüsselung der Einnahmen und Ausgaben
Wie Semler Scientific Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Jun 24 | 62 | 16 | 28 | 5 |
31 Mar 24 | 66 | 22 | 30 | 5 |
31 Dec 23 | 68 | 21 | 32 | 6 |
30 Sep 23 | 67 | 20 | 32 | 6 |
30 Jun 23 | 65 | 18 | 32 | 6 |
31 Mar 23 | 61 | 16 | 31 | 5 |
31 Dec 22 | 57 | 14 | 30 | 5 |
30 Sep 22 | 54 | 13 | 29 | 5 |
30 Jun 22 | 54 | 13 | 28 | 4 |
31 Mar 22 | 54 | 16 | 27 | 4 |
31 Dec 21 | 53 | 17 | 24 | 4 |
30 Sep 21 | 54 | 21 | 22 | 3 |
30 Jun 21 | 50 | 22 | 19 | 3 |
31 Mar 21 | 42 | 16 | 17 | 3 |
31 Dec 20 | 39 | 14 | 16 | 3 |
30 Sep 20 | 36 | 11 | 16 | 3 |
30 Jun 20 | 34 | 14 | 17 | 3 |
31 Mar 20 | 35 | 16 | 17 | 3 |
31 Dec 19 | 33 | 15 | 16 | 2 |
30 Sep 19 | 30 | 14 | 15 | 2 |
30 Jun 19 | 26 | 7 | 13 | 2 |
31 Mar 19 | 24 | 6 | 12 | 2 |
31 Dec 18 | 21 | 5 | 11 | 2 |
30 Sep 18 | 20 | 4 | 11 | 2 |
30 Jun 18 | 18 | 2 | 10 | 2 |
31 Mar 18 | 15 | 0 | 10 | 2 |
31 Dec 17 | 12 | -2 | 9 | 2 |
30 Sep 17 | 11 | -2 | 8 | 2 |
30 Jun 17 | 9 | -2 | 7 | 1 |
31 Mar 17 | 8 | -2 | 7 | 1 |
31 Dec 16 | 7 | -3 | 7 | 1 |
30 Sep 16 | 8 | -7 | 10 | 1 |
30 Jun 16 | 7 | -8 | 11 | 1 |
31 Mar 16 | 7 | -8 | 11 | 1 |
31 Dec 15 | 7 | -9 | 11 | 1 |
30 Sep 15 | 5 | -5 | 8 | 1 |
30 Jun 15 | 4 | -5 | 8 | 1 |
31 Mar 15 | 4 | -5 | 7 | 1 |
31 Dec 14 | 4 | -5 | 6 | 1 |
30 Sep 14 | 3 | -4 | 5 | 1 |
30 Jun 14 | 3 | -3 | 4 | 1 |
31 Mar 14 | 3 | -2 | 4 | 0 |
31 Dec 13 | 2 | -2 | 4 | 0 |
Qualität der Erträge: SMLR has a high level of non-cash earnings.
Wachsende Gewinnspanne: SMLR's current net profit margins (25.6%) are lower than last year (27.4%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: SMLR's earnings have grown by 7.7% per year over the past 5 years.
Beschleunigtes Wachstum: SMLR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: SMLR had negative earnings growth (-10.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (11.7%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: SMLR's Return on Equity (20.2%) is considered high.